Top Markets
Coin of the day
IntegraGen SA IntegraGen SA

IntegraGen SA

ALINT
Rang in aandelen #19673
IntegraGen SA provides human genome analysis services for academic researcher... IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Aandeelprijs
$0.20876331
Marktkapitalisatie
$1.38M
Verandering (1 dag)
1.15%
Verandering (1 jaar)
-64.84%
Land
FR
Handel IntegraGen SA (ALINT)

Categorie

Winst voor IntegraGen SA (ALINT)
Winst in Dec 2025 TTM: $-3.23M
Volgens de meest recente financiële verslagen van IntegraGen SA bedraagt de huidige winst van het bedrijf $-3.23M. In 2023 behaalde het bedrijf een winst van $-286.40K, een daling ten opzichte van de winst van 2022, die $-153.95K bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van IntegraGen SA van 2008 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-3.23M 782.69%
2024 $-366.28K 27.89%
2023 $-286.40K 86.04%
2022 $-153.95K 18.42%
2021 $-130.00K -77.17%
2020 $-569.29K 15.84%
2019 $-491.43K -67.91%
2018 $-1.53M 6.75%
2017 $-1.43M -29.04%
2016 $-2.02M 0.08%
2015 $-2.02M 10.76%
2014 $-1.82M -54.01%
2013 $-3.96M 29.95%
2012 $-3.05M -5.30%
2011 $-3.22M -31.40%
2010 $-4.70M -3.84%
2009 $-4.88M -6.08%
2008 $-5.20M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$24.72B -764,615.67%
DK
$5.17B -159,875.15%
US
$5.16B -159,602.96%
US
$2.14B -66,218.92%
BE
$1.66B -51,304.66%
NL